-
公开(公告)号:BR9509055A
公开(公告)日:1998-06-23
申请号:BR9509055
申请日:1995-09-19
Applicant: BASF AG
Inventor: HOFMANN HANS PETER , TREIBER HANS-JORG , LUBISCH WILFRIED , BEHL BERTHOLD
IPC: A61K31/495 , A61P9/00 , A61P25/00 , A61P25/08 , A61P25/24 , A61P25/26 , C07D487/04
-
192.
公开(公告)号:CA2265509A1
公开(公告)日:1998-03-19
申请号:CA2265509
申请日:1997-08-22
Applicant: BASF AG
Inventor: WICKE KARSTEN , KERRIGAN FRANK , EMLING FRANZ , CHEETHAM SHARON , BEHL BERTHOLD , LUBISCH WILFRIED , BACH ALFRED , TESCHENDORF HANS-JUERGEN , STEINER GERD
IPC: A61K31/435 , A61K31/519 , A61P25/24 , A61P43/00 , C07D211/00 , C07D239/00 , C07D333/00 , C07D495/14
Abstract: The invention concerns 3-substituted 3,4,5,6,7,8-hexahydro-pyrido¢4,3':4,5!thieno-¢2,3-d!pyrimidine derivatives of formula (I) in which: R1 designates a hydrogen atom, a C1-C4 alkyl group, an acetyl or benzoyl group, a phenylalkyl C1-C4 group - the aromatic optionally being substituted by halogen, C1-C4 alkyl, trifluoromethyl, hydroxy, C1-C4 alkoxy, amino, cyano or nitro groups - a naphthylalkyl C1-C3 group, a phenylalkanone C2-C3 group or a phenylcarbamoylalkyl C2 group, wherein the phenyl group can be substituted by halogen; R2 designates a phenyl, pyridyl, pyrimidinyl or pyrazinyl group which can optionally be mono-, di- or tri-substituted by halogen atoms, C1-C4 alkyl, trifluoromethyl, trifluoromethoxy, hydroxy, C1-C4 alkoxy, amino, monomethylamino, dimethylamino, cyano or nitro groups and can optionally be anellated with a benzene nucleus, which can optionally be mono- or disubstituted by halogen atoms, C1-C4 alkyl, hydroxy, trifluoromethyl, C1-C4 alkoxy, amino, cyano or nitro groups and can optionally contain 1 nitrogen atom, or with a 5- or 6-member ring which can contain between 1 and 2 oxygen atoms, or can be substituted by a phenyl-C1-C2 alkyl or alkoxy group, wherein the phenyl group can be substituted by halogen, a methyl, trifluoromethyl or methoxy group; A designates NH or an oxygen atom; B designates hydrogen or methyl; C designates hydrogen, methyl or hydroxy; X designates a nitrogen atom; Y is CH2, CH2-CH2, CH2-CH2-CH2 or CH2-CH; Z designates a nitrogen atom, a carbon atom or CH, wherein the bond between Y and Z can also be a double bond; and n is the number 2, 3 or 4, and their physiologically compatible salts. These compounds are suitable as medicaments for treating diseases in which the serotonin concentration is reduced and in which the activity of the presynaptic receptors 5-HT1B, 5-HT1A, 5HT1D is to be blocked within a therapeutic context without greatly influencing other receptors. Such diseases include, for example, depression.
-
公开(公告)号:MX9700113A
公开(公告)日:1997-12-31
申请号:MX9700113
申请日:1995-06-16
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , BEHL BERTHOLD , HOFMANN HANS PETER
IPC: C07D241/44 , A61K31/495 , A61P25/00 , A61P25/08 , A61P25/24 , A61P25/26 , C07D20060101 , C07D241/54 , C07D403/04
Abstract: La presente invencion se refiere a amido-quinoxalindionas novedosas de la formula (I), en donde R1 a R5, n y m tienen los significados indicados en la descripcion, y a su preparacion. Los compuestos son adecuados para el tratamiento de enfermedades.
-
公开(公告)号:SG44782A1
公开(公告)日:1997-12-19
申请号:SG1996007476
申请日:1993-06-08
Applicant: BASF AG
Inventor: BEHL BERTHOLD , STEINER GERD , TESCHEN-DORF HANS-JUERGEN , UNGER LILIANE , MUNSCHAUER RAINER
IPC: A61K20060101 , A61K31/33 , A61K31/395 , A61K31/40 , A61K31/4045 , A61K31/4184 , A61K31/505 , A61K31/506 , C07D513/04 , A61K31/513 , A61K31/517 , A61K31/519 , A61K31/54 , A61K31/542 , A61P25/00 , A61P25/20 , A61P25/22 , A61P25/24 , A61P43/00 , C07D20060101 , C07D207/00 , C07D209/02 , C07D209/52 , C07D221/00 , C07D239/00 , C07D401/04 , C07D401/06 , C07D401/14 , C07D403/00 , C07D403/04 , C07D403/06 , C07D403/14 , C07D409/04 , C07D409/06 , C07D409/14 , C07D417/14 , C07D471/04 , C07D487/04 , C07D495/04
Abstract: PCT No. PCT/EP93/01438 Sec. 371 Date Dec. 16, 1994 Sec. 102(e) Date Dec. 16, 1994 PCT Filed Jun. 8, 1993 PCT Pub. No. WO94/00458 PCT Pub. Date Jan. 6, 1994.Abstract of the Disclosure: Compounds of the formula I I where R1, R2, n , R3, A, X, Y and Z have the meanings stated in the description, and the preparation thereof are described. The novel compounds are suitable for controlling diseases , i.e., as neuroleptics, antidepressants, sedatives, hypnotics, CNS protectives or muscle relaxants.
-
公开(公告)号:DK0647231T3
公开(公告)日:1997-09-29
申请号:DK93912910
申请日:1993-06-08
Applicant: BASF AG
Inventor: STEINER GERD , UNGER LILIANE , TESCHENDORF HANS-JUERGEN , BEHL BERTHOLD , MUNSCHAUER RAINER
IPC: C07D513/04 , A61K20060101 , A61K31/33 , A61K31/395 , A61K31/40 , A61K31/4045 , A61K31/4184 , A61K31/505 , A61K31/506 , A61K31/513 , A61K31/517 , A61K31/519 , A61K31/54 , A61K31/542 , A61P25/00 , A61P25/20 , A61P25/22 , A61P25/24 , A61P43/00 , C07D20060101 , C07D207/00 , C07D209/02 , C07D209/52 , C07D221/00 , C07D239/00 , C07D401/04 , C07D401/06 , C07D401/14 , C07D403/00 , C07D403/04 , C07D403/06 , C07D403/14 , C07D409/04 , C07D409/06 , C07D409/14 , C07D417/14 , C07D471/04 , C07D487/04 , C07D495/04
Abstract: PCT No. PCT/EP93/01438 Sec. 371 Date Dec. 16, 1994 Sec. 102(e) Date Dec. 16, 1994 PCT Filed Jun. 8, 1993 PCT Pub. No. WO94/00458 PCT Pub. Date Jan. 6, 1994.Abstract of the Disclosure: Compounds of the formula I I where R1, R2, n , R3, A, X, Y and Z have the meanings stated in the description, and the preparation thereof are described. The novel compounds are suitable for controlling diseases , i.e., as neuroleptics, antidepressants, sedatives, hypnotics, CNS protectives or muscle relaxants.
-
公开(公告)号:PL319660A1
公开(公告)日:1997-08-18
申请号:PL31966095
申请日:1995-10-02
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , VIERLING MICHAEL , BEHL BERTHOLD , HOFMANN HANS PETER
IPC: A61K31/495 , A61P25/00 , A61P43/00 , C07D403/04
Abstract: PCT No. PCT/EP95/03902 Sec. 371 Date Mar. 27, 1997 Sec. 102(e) Date Mar. 27, 1997 PCT Filed Oct. 2, 1995 PCT Pub. No. WO90/11922 PCT Pub. Date Apr. 25, 1996Pyrrolyltetrahydrobenzoquinoxalinediones of the formula I I and their tautomeric and isomeric forms, and their physiologically tolerated salts, in which the variables have the meanings stated in the description, and the preparation thereof are described. The novel compounds are antagonists of the glutamate receptor subtypes and are thus suitable for controlling various diseases.
-
公开(公告)号:PL317967A1
公开(公告)日:1997-05-12
申请号:PL31796795
申请日:1995-06-16
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , BEHL BERTHOLD , HOFMANN HANS PETER
IPC: C07D241/44 , A61K31/495 , A61P25/00 , A61P25/08 , A61P25/24 , A61P25/26 , C07D20060101 , C07D241/54 , C07D403/04
Abstract: PCT No. PCT/EP95/02324 Sec. 371 Date Dec. 20, 1996 Sec. 102(e) Date Dec. 20, 1996 PCT Filed Jun. 16, 1995 PCT Pub. No. WO95/35289 PCT Pub. Date Dec. 28, 1995Novel amido-quinoxalinediones of the formula I where R1-R5, n and m have the meanings stated in the description, and the preparation thereof are described. The compounds are suitable for controlling diseases.
-
公开(公告)号:DE59305812D1
公开(公告)日:1997-04-17
申请号:DE59305812
申请日:1993-11-27
Applicant: BASF AG
Inventor: SCHLECKER RAINER , TREIBER HANS-JOERG , BEHL BERTHOLD , HOFMANN HANS
IPC: A61K31/505 , A61K31/55 , A61P9/10 , A61P25/00 , A61P25/06 , A61P25/08 , A61P25/16 , A61P25/24 , A61P25/28 , C07D471/14 , C07D487/04 , C07D487/14 , C07D491/044 , C07D491/147 , C07D495/14
Abstract: Triazolopyrimidines of the formula I where A, D and X have the meanings stated in the description, and their preparation are described. The novel compounds are suitable for controlling diseases.
-
公开(公告)号:ES2098119T3
公开(公告)日:1997-04-16
申请号:ES94901897
申请日:1993-11-27
Applicant: BASF AG
Inventor: SCHLECKER RAINER , TREIBER HANS-JOERG , BEHL BERTHOLD , HOFMANN HANS PETER
IPC: A61K31/505 , A61P25/02 , A61P25/20 , C07D487/04
Abstract: PCT No. PCT/EP93/03331 Sec. 371 Date Jun. 1, 1995 Sec. 102(e) Date Jun. 1, 1995 PCT Filed Nov. 27, 1993 PCT Pub. No. WO94/13672 PCT Pub. Date Jun. 23, 1994Novel triazoloquinazolines of the formula I gs stated in the description, and their preparation are described. The compounds are suitable for controlling diseases.
-
公开(公告)号:ZA9508643B
公开(公告)日:1997-04-14
申请号:ZA9508643
申请日:1995-10-13
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , VIERLING MICHAEL , BEHL BERTHOLD , HOFMANN HANS PETER
IPC: A61K31/495 , A61P25/00 , A61P43/00 , C07D403/04 , C07D , A61K
CPC classification number: C07D403/04
-
-
-
-
-
-
-
-
-